Professor Yoni Freedhoff claimed that changing eating and exercise habits will never be as effective as weight-loss drugs ...

The FDA has declared an end to the shortage of a popular obesity drug. The implications for consumers are complicated.

New research suggests popular weight loss medications containing semaglutide may increase risk of rare vision condition, but ...

Eli Lilly (LLY) emerges among the top performers in Big Pharma in 2024 with obesity drug success, while Novo Nordisk (NVO) ...

Both companies are longtime leaders in the pharmaceutical industry and have been making breakthroughs and delivering ...

Although Novo will still make a mind-blowing amount of money from its existing obesity drugs in the coming years (its ...

Elon Musk has revealed he has upgraded from Ozempic to Mounjaro, nicknamed the “King Kong” of weight-loss drugs, in a photo ...

By aiding weight loss, Zepbound can improve symptoms of obstructive sleep apnea (OSA) in people with obesity — but CPAP ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 500.39% and ...

GLP-1 receptor agonist weight loss drugs can negatively interact with eating disorder psychopathology and treatment in ...

Elon Musk has dished the secrets behind his recent weight loss transformation.